These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29298114)

  • 1. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
    Vulaj V; Hough S; Bedard L; Farris K; Mackler E
    J Oncol Pract; 2018 Jun; 14(6):e403-e411. PubMed ID: 29298114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using quality oncology practice initiative metrics for physician incentive compensation.
    Makari-Judson G; Wrenn T; Mertens WC; Josephson G; Stewart JA
    J Oncol Pract; 2014 Jan; 10(1):58-62. PubMed ID: 24151329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing Quality Oncology Practice Initiative (QOPI) participation in a community oncology practice.
    Peterson J
    J Registry Manag; 2012; 39(4):154-7. PubMed ID: 23493020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Quality Oncology Practice Initiative (QOPI) Measure Adherence Between Oncology Fellows, Advanced Practice Providers, and Attending Physicians.
    Zhu J; Zhang T; Shah R; Kamal AH; Kelley MJ
    J Cancer Educ; 2015 Dec; 30(4):774-8. PubMed ID: 25686787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended quality measures for health-system pharmacy: 2019 update from the Pharmacy Accountability Measures Work Group.
    Andrawis M; Ellison LTCC; Riddle S; Mahan KC; Collins CD; Brummond P; Carmichael J
    Am J Health Syst Pharm; 2019 Jun; 76(12):874-887. PubMed ID: 31361855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
    Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
    J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
    Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
    J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacist in improving quality measures that affect payments to physicians.
    Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clinical pharmacists in outpatient oncology practices: A review.
    Gatwood J; Gatwood K; Gabre E; Alexander M
    Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best practices in specialty pharmacy management.
    Patterson CJ
    J Manag Care Pharm; 2013; 19(1):42-8. PubMed ID: 23383699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicaid reimbursement for pharmacist services: A strategy for the pharmacy profession.
    Schweitzer P; Atalla M
    Am J Health Syst Pharm; 2021 Feb; 78(5):408-415. PubMed ID: 33605989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Quality Oncology Practice Initiative Metrics in Solid Tumor Oncology Clinic With or Without Concomitant Supportive Oncology Consultation.
    Rosenblum R; Huo R; Scarborough B; Goldstein N; Smith CB
    J Oncol Pract; 2018 Dec; 14(12):e786-e793. PubMed ID: 30537452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Cancer Care Through Quality Initiatives: The Uganda Cancer Institute Experience With the Quality Oncology Practice Initiative.
    Bogere N; Were E; Asasira J; Orem J
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432104. PubMed ID: 38862140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.
    Mackler E; Segal EM; Muluneh B; Jeffers K; Carmichael J
    J Oncol Pract; 2019 Apr; 15(4):e346-e355. PubMed ID: 30860937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements.
    American Pharmacists Association Foundation and American Pharmacists Association
    J Am Pharm Assoc (2003); 2013; 53(2):e132-41. PubMed ID: 23571636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
    Smith M; Cannon-Breland ML; Spiggle S
    Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.